2019
Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia
Tong J, Huang J, Luo X, Chen S, Cui Y, An H, Xiu M, Tan S, Wang Z, Yuan Y, Zhang J, Yang F, Li CR, Hong L, Tan Y. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia. Brain Behavior And Immunity 2019, 81: 213-219. PMID: 31201848, PMCID: PMC6754783, DOI: 10.1016/j.bbi.2019.06.017.Peer-Reviewed Original ResearchConceptsN-methyl-D-aspartate (NMDA) glutamate receptorsFirst-episode patientsNMDAR antibodiesAntibody levelsHealthy controlsSerum anti-NMDAR antibodyTotal scoreAnti-NMDAR antibodiesNMDAR antibody levelsNMDAR-antibody encephalitisElevated levelsReceptor antibody levelsSerum antibody levelsTreatment of schizophreniaPathogenesis of schizophreniaNegative Syndrome ScaleSymptoms of psychosisEnzyme-linked immunosorbentEtiology of schizophreniaMCCB total scoreAntibody encephalitisPatient groupNMDAR dysfunctionSchizophrenia (MATRICS) Consensus Cognitive BatteryGlutamate receptors
2016
Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals
Xu L, Zhang T, Zheng L, Li H, Tang Y, Luo X, Sheng J, Wang J. Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals. PLOS ONE 2016, 11: e0148935. PMID: 26859774, PMCID: PMC4747512, DOI: 10.1371/journal.pone.0148935.Peer-Reviewed Original ResearchConceptsProdromal Questionnaire-Brief VersionClinical high riskHelp-seeking individualsProdromal QuestionnaireHelp-seeking outpatientsPreliminary epidemiological studyLogistic regression modelsPsychometric propertiesOutpatient clinicPresent studyCHR subjectsProdromal individualsHigh riskEpidemiological studiesPsychotic diagnosesPositive diagnosisSIPS diagnosesDistress scoresProdromal SyndromesConcordant validityPsychosisDiagnosisTotal scoreOutpatient sampleCutoff score